{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:49:22Z","timestamp":1787507362904,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N93019C00052"],"award-info":[{"award-number":["75N93019C00052"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008065","name":"Georgia Research Alliance","doi-asserted-by":"publisher","award":["GRA-001"],"award-info":[{"award-number":["GRA-001"]}],"id":[{"id":"10.13039\/100008065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.virol.2024.110119","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T11:03:10Z","timestamp":1717239790000},"page":"110119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes"],"prefix":"10.1016","volume":"597","author":[{"given":"Pan","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2024.110119_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.abm0271","article-title":"A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes","volume":"378","author":"Arevalo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.virol.2024.110119_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv067","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection against seasonal A\/H3N2 influenza disease","volume":"2","author":"Benoit","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.virol.2024.110119_bib3","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.vaccine.2021.02.075","article-title":"Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses","volume":"39","author":"Bertran","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110119_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.smim.2004.02.004","article-title":"CD4 T cell responses to influenza infection","volume":"16","author":"Brown","year":"2004","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.virol.2024.110119_bib5","article-title":"Evaluation of two adjuvant formulations for an inactivated Yellow Fever 17DD vaccine candidate in mice","volume":"11","author":"Cajaraville","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2024.110119_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02090-20","article-title":"H1 hemagglutinin priming provides long-lasting heterosubtypic immunity against H5N1 challenge in the mouse model","volume":"11","author":"Carreno","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.virol.2024.110119_bib7","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.03152-15","article-title":"Design and Characterization of a computationally optimized broadly reactive hemagglutinin vaccine for H1N1 influenza viruses","volume":"90","author":"Carter","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110119_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/21645515.2015.1012013","article-title":"Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades","volume":"11","author":"Crevar","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virol.2024.110119_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.vaccine.2012.12.013","article-title":"High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season","volume":"31","author":"DiazGranados","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110119_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the National Institute of Allergy and infectious diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110119_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181738","article-title":"A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques","volume":"12","author":"Florek","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2024.110119_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/v11020122","article-title":"Back to the future for influenza Preimmunity-Looking back at influenza virus history to infer the Outcome of future infections","volume":"11","author":"Francis","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2024.110119_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/v15010203","article-title":"Evaluation of pre-pandemic trivalent COBRA HA vaccine in mice pre-immune to historical H1N1 and H3N2 influenza viruses","volume":"15","author":"Ge","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2024.110119_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1750-2659.2008.00038.x","article-title":"Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs","volume":"2","author":"Geeraedts","year":"2008","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.virol.2024.110119_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/CVI.05533-11","article-title":"Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle","volume":"19","author":"Giles","year":"2012","journal-title":"vaccines. Clin Vaccine Immunol"},{"key":"10.1016\/j.virol.2024.110119_bib16","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/infdis\/jis232","article-title":"A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection","volume":"205","author":"Giles","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110119_bib17","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.vaccine.2011.01.100","article-title":"A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets","volume":"29","author":"Giles","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110119_bib18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1126\/science.aag1322","article-title":"Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting","volume":"354","author":"Gostic","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.virol.2024.110119_bib19","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1016\/j.vaccine.2017.06.039","article-title":"M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza","volume":"35","author":"Hatta","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110119_bib20","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J. Hyg."},{"key":"10.1016\/j.virol.2024.110119_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virol.2024.110119_bib22","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/0264-410X(95)00127-M","article-title":"Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans","volume":"13","author":"Kilbourne","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110119_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virol.2024.110119_bib24","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/infdis\/jiy711","article-title":"Universal influenza virus vaccines that Target the conserved hemagglutinin stalk and conserved Sites in the head domain","volume":"219","author":"Krammer","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110119_bib25","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110119_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1473-3099(13)70038-0","article-title":"AS03-adjuvanted influenza vaccine in elderly people","volume":"13","author":"Ledgerwood","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2024.110119_bib27","article-title":"Influenza A(H7N9) pandemic Preparedness: assessment of the breadth of heterologous antibody responses to emerging viruses from multiple pre-pandemic vaccines and population immunity","volume":"10","author":"Levine","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.virol.2024.110119_bib53","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/tbed.13515","article-title":"Control of avian influenza in China: strategies and lessons","volume":"67","author":"Liu","year":"2020","journal-title":"Transbound Emerg. Dis."},{"key":"10.1016\/j.virol.2024.110119_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101474","article-title":"Alum and squalene-oil-in-water emulsion enhance the titer and avidity of anti-Abeta antibodies induced by multimeric protein antigen (1-11)E2, preserving the Igg1-skewed isotype distribution","volume":"9","author":"Mantile","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2024.110119_bib29","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an Independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110119_bib30","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/eji.201242922","article-title":"Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine","volume":"43","author":"Mullarkey","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virol.2024.110119_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/npjvaccines.2016.15","article-title":"A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice","volume":"1","author":"Nachbagauer","year":"2016","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.virol.2024.110119_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2017.02.009","article-title":"Universal influenza virus vaccines and therapeutic antibodies","volume":"23","author":"Nachbagauer","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.virol.2024.110119_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10111352","article-title":"Next-generation computationally designed influenza hemagglutinin vaccines protect against H5Nx virus infections","volume":"10","author":"Nunez","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.virol.2024.110119_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1286758","article-title":"Influenza virus immune imprinting dictates the clinical outcomes in ferrets challenged with highly pathogenic avian influenza virus H5N1","volume":"10","author":"Nunez","year":"2023","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.virol.2024.110119_bib35","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.vaccine.2019.10.097","article-title":"Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses","volume":"38","author":"Nunez","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110119_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/erv.12.140","article-title":"The history of MF59((R)) adjuvant: a phoenix that arose from the ashes","volume":"12","author":"O'Hagan","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2024.110119_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01526-20","article-title":"Computationally optimized broadly reactive H2 HA influenza vaccines elicited broadly cross-reactive antibodies and protected mice from viral challenges","volume":"95","author":"Reneer","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110119_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00052-21","article-title":"Broadly reactive H2 hemagglutinin vaccines elicit cross-reactive antibodies in ferrets Preimmune to seasonal influenza A viruses","volume":"6","author":"Reneer","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.virol.2024.110119_bib39","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1016\/j.vaccine.2019.07.058","article-title":"Corrigendum to \"A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains\"","volume":"37","author":"Ross","year":"2019","journal-title":"Vaccine"},{"issue":"Pt 7","key":"10.1016\/j.virol.2024.110119_bib40","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1099\/0022-1317-77-7-1483","article-title":"The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region","volume":"77","author":"Sagawa","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2024.110119_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00759-21","article-title":"Universal influenza virus neuraminidase vaccine elicits protective immune responses against human seasonal and pre-pandemic strains","volume":"95","author":"Skarlupka","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110119_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/v15010184","article-title":"Multi-influenza HA subtype protection of ferrets vaccinated with an N1 COBRA-based neuraminidase","volume":"15","author":"Skarlupka","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2024.110119_bib43","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1016\/j.vaccine.2017.08.021","article-title":"Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes","volume":"35","author":"Smith","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110119_bib44","article-title":"Host receptors of influenza viruses and Coronaviruses-Molecular mechanisms of Recognition","volume":"8","author":"Sriwilaijaroen","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2024.110119_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02241-21","article-title":"A novel recombinant influenza virus neuraminidase vaccine candidate Stabilized by a Measles virus Phosphoprotein tetramerization domain provides robust protection from virus challenge in the mouse model","volume":"12","author":"Strohmeier","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.virol.2024.110119_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00333-19","article-title":"Development of influenza B universal vaccine candidates using the \"mosaic\" hemagglutinin Approach","volume":"93","author":"Sun","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110119_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014442","article-title":"Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin","volume":"5","author":"Talbot","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2024.110119_bib48","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41598-023-51024-0","article-title":"Multivalent next generation influenza virus vaccines protect against seasonal and pre-pandemic viruses","volume":"14","author":"Uno","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2024.110119_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.virol.2024.110119_bib50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1126\/science.1192517","article-title":"Induction of broadly neutralizing H1N1 influenza antibodies by vaccination","volume":"329","author":"Wei","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.virol.2024.110119_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004273","article-title":"Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure","volume":"4","author":"Wei","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virol.2024.110119_bib52","article-title":"The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants","volume":"7","author":"Wong","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224001405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224001405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:57:13Z","timestamp":1762221433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682224001405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":53,"alternative-id":["S0042682224001405"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2024.110119","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2024.110119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110119"}}